Claude Méric

2.2k total citations
24 papers, 1.7k citations indexed

About

Claude Méric is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Claude Méric has authored 24 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Virology and 7 papers in Epidemiology. Recurrent topics in Claude Méric's work include Cytomegalovirus and herpesvirus research (7 papers), Mosquito-borne diseases and control (6 papers) and Herpesvirus Infections and Treatments (6 papers). Claude Méric is often cited by papers focused on Cytomegalovirus and herpesvirus research (7 papers), Mosquito-borne diseases and control (6 papers) and Herpesvirus Infections and Treatments (6 papers). Claude Méric collaborates with scholars based in France, United States and Hungary. Claude Méric's co-authors include P F Spahr, Stephen P. Goff, Stanley A. Plotkin, Éva Gönczöl, Édouard W. Khandjian, Klára Berencsi, M. Cadoz, Jean-Luc Darlix, Emmanuel Feroldi and John M. Zahradnik and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Molecular Biology and Analytical Biochemistry.

In The Last Decade

Claude Méric

24 papers receiving 1.7k citations

Peers

Countries citing papers authored by Claude Méric

Since Specialization

Citations

This map shows the geographic impact of Claude Méric's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude Méric with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude Méric more than expected).

Fields of papers citing papers by Claude Méric

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claude Méric. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude Méric. The network helps show where Claude Méric may publish in the future.

Co-authorship network of co-authors of Claude Méric

This figure shows the co-authorship network connecting the top 25 collaborators of Claude Méric. A scholar is included among the top collaborators of Claude Méric based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claude Méric. Claude Méric is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Primary Immunization of Infants and Toddlers in Thailand with Japanese Encephalitis Chimeric Virus Vaccine in Comparison with SA14-14-2 2014 ·The Pediatric Infectious Disease Journal ·Emmanuel Feroldi, Chitsanu Pancharoen, Pope Kosalaraksa, Kulkanya Chokephaibulkit, Mark Boaz, Claude Méric, Yanee Hutagalung, Alain Bouckenooghe	28
2	Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from South-East Asia and India 2014 ·BMC Infectious Diseases ·Matthew Bonaparte, (unknown), Emmanuel Feroldi, Claude Méric, Alain Bouckenooghe, Stephen W. Hildreth, Branda Hu, Sutee Yoksan, Mark Boaz	22
3	Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children 2013 ·Human Vaccines & Immunotherapeutics ·Emmanuel Feroldi, María Rosario Capeding, Mark Boaz, Sophia Gailhardou, Claude Méric, Alain Bouckenooghe	26
4	Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine : randomized, double-blind, 5-year phase II study in healthy adults. 2011 ·QUT ePrints (Queensland University of Technology) ·Peter Nasveld, (unknown), (unknown), (unknown), Sutee Yoksan, John Aaskov, Karen McCarthy, Niranjan Kanesa-thasan, Claude Méric, Mark Reid	2
5	Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials 2010 ·Vaccine ·Joseph Torresi, Karen McCarthy, Emmanuel Feroldi, Claude Méric	45
6	Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine 2010 ·Human Vaccines ·Peter Nasveld, (unknown), (unknown), (unknown), Sutee Yoksan, John Aaskov, Karen McCarthy, Niranjan Kanesa-thasan, Claude Méric, Mark Reid	45
7	Use of predictive markers of HIV disease progression in vaccine trials 2009 ·Vaccine ·Sanjay Gurunathan, Raphaëlle El Habib, Lynn Baglyos, Claude Méric, S. A. Plotkin, Betty Dodet, Lawrence Corey, J. Tartaglia	16
8	Lack of induction of autoantibody responses following immunization with cytomegalovirus (CMV) glycoprotein B (gB) in healthy CMV-seronegative subjects 2004 ·Vaccine ·Mark R. Schleiss, David I. Bernstein, Murray H. Passo, Susan Parker, Claude Méric, F. Verdier, Marianna M. Newkirk	9
9	Effect of Previous or Simultaneous Immunization with Canarypox Expressing Cytomegalovirus (CMV) Glycoprotein B (gB) on Response to Subunit gB Vaccine plus MF59 in Healthy CMV‐Seronegative Adults 2002 ·The Journal of Infectious Diseases ·David I. Bernstein, Mark R. Schleiss, Klára Berencsi, Éva Gönczöl, Michelle Dickey, (unknown), M. Cadoz, Claude Méric, John M. Zahradnik, Anne‐Marie Duliège, Stanley A. Plotkin	55
10	Electric pulses increase the immunogenicity of an influenza DNA vaccine injected intramuscularly in the mouse 2001 ·Vaccine ·(unknown), Florence Boudet, Michel F. Bureau, Yves Girerd-Chambaz, Pierre Wils, Daniel Scherman, Claude Méric	64
11	Optimization of DNA immunization against human cytomegalovirus 2001 ·Vaccine ·Valéria Endrész, Katalin Burián, Klára Berencsi, Z. Gyulai, Laszlo Kari, Holly M. Horton, (unknown), Claude Méric, Stanley A. Plotkin, Éva Gönczöl	27
12	A Canarypox Vector–Expressing Cytomegalovirus (CMV) Phosphoprotein 65 Induces Long‐Lasting Cytotoxic T Cell Responses in Human CMV‐Seronegative Subjects 2001 ·The Journal of Infectious Diseases ·Klára Berencsi, Zsófia Gyulai, Éva Gönczöl, S Pincus, William I. Cox, S. Michelson, Laszlo Kari, Claude Méric, M. Cadoz, John M. Zahradnik, Stuart E. Starr, Stanley A. Plotkin	115
13	Implication of γδ T cells in the human immune response to cytomegalovirus 1999 ·Journal of Clinical Investigation ·Julie Déchanet, Pierre Merville, Apiradee Lim, Christelle Retière, Vincent Pitard, Xavier Lafarge, (unknown), Claude Méric, Marie‐Martine Hallet, Philippe Kourilsky, L. Potaux, Marc Bonneville, Jean‐François Moreau	258
14	Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunization 1999 ·Vaccine ·Valéria Endrész, Laszlo Kari, Klára Berencsi, Csaba Kari, Zsófia Gyulai, Csaba Jeney, S Pincus, Ulrich Rodeck, Claude Méric, Stanley A. Plotkin, Éva Gönczöl	47
15	A Canarypox Vector Expressing Cytomegalovirus (CMV) Glycoprotein B Primes for Antibody Responses to a Live Attenuated CMV Vaccine (Towne) 1999 ·The Journal of Infectious Diseases ·Stuart P. Adler, Stanley A. Plotkin, Éva Gönczöl, M. Cadoz, Claude Méric, Jian Ben Wang, P. Dellamonica, Al M. Best, John M. Zahradnik, S Pincus, Klára Berencsi, William I. Cox, Zsófia Gyulai	94
16	A Prime-Boost Approach to HIV Preventive Vaccine Using a Recombinant Canarypox Virus Expressing Glycoprotein 160 (MN) followed by a Recombinant Glycoprotein 160 (MN/LAI) 1995 ·AIDS Research and Human Retroviruses ·Gilles Pialoux, Jean‐Louis Excler, Yves Rivière, Gustavo Gonzalez-Canali, V. Feuillie, (unknown), Jean‐Claude Gluckman, Thomas J. Matthews, Bernard Meignier, Marie-Paule Kiény, (unknown), (unknown), Claude Méric, Enzo Paoletti, James Tartaglia, Horacio Salomón, Stanley A. Plotkin, (unknown), (unknown)	104
17	The safety and use of canarypox vectored vaccines. 1995 ·PubMed ·S. A. Plotkin, M. Cadoz, Bernard Meignier, Claude Méric, Odile Leroy, Jean‐Louis Excler, James Tartaglia, Enzo Paoletti, Éva Gönczöl, G. Chappuis	55
18	Respiratory syncytial virus nucleocapsid protein (N) expressed in insect cells forms nucleocapsid-like structures 1994 ·Virus Research ·Claude Méric, Danièle Spehner, V. Mazarin	22
19	Mutations in Rous sarcoma virus nucleocapsid protein p12 (NC): deletions of Cys-His boxes 1988 ·Journal of Virology ·Claude Méric, (unknown), P F Spahr	119
20	A procedure for Northern blot analysis of native RNA 1986 ·Analytical Biochemistry ·Édouard W. Khandjian, Claude Méric	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact